Search

everythinglearnresearchcommunity

for

Search:↓

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Biosimilars lower costs but don't significantly improve access.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Tocilizumab might be an effective treatment for COVID-19.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

BCG site reactions after COVID-19 mRNA vaccination are mild, temporary, and likely under-reported.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Anti-CD19 therapy may help treat SLE and NMOSD.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Blocking interferon-gamma might help treat various autoimmune diseases.